These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17261625)

  • 1. Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing.
    Credito K; Lin G; Appelbaum PC
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1508-11. PubMed ID: 17261625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
    Samra Z; Ofer O; Shmuely H
    Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
    Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA).
    Leonard SN; Szeto YG; Zolotarev M; Grigoryan IV
    Int J Antimicrob Agents; 2011 Jun; 37(6):558-61. PubMed ID: 21497067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The combined effect of methicillin and teicoplanin against Staphylococcus aureus strains investigated in vitro].
    Młynarczyk A; Młynarczyk G; Luczak M
    Med Dosw Mikrobiol; 2005; 57(1):1-6. PubMed ID: 16130290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin.
    Tsuji BT; Rybak MJ
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):73-7. PubMed ID: 16368477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of linezolid and teicoplanin on skin staphylococci.
    Hayman S; Wilson AP; Singer M; Bellingan G
    J Antimicrob Chemother; 2007 Jun; 59(6):1281-2. PubMed ID: 17412723
    [No Abstract]   [Full Text] [Related]  

  • 14. False synergy between vancomycin and beta-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods.
    Goldstein FW; Atoui R; Ben Ali A; Nguyen JC; Ly A; Kitzis MD
    Clin Microbiol Infect; 2004 Apr; 10(4):342-5. PubMed ID: 15059127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT; Liao CH; Teng LJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
    Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
    Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
    J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin.
    Pankey G; Ashcraft D; Patel N
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5166-8. PubMed ID: 16304195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal inhibitory concentration drift of glycopeptides and linezolid against S. Aureus at a Chinese children's center, 2009-2013.
    Jing CM; Xie W; Chen Y; Wang C
    Pediatr Infect Dis J; 2015 Jan; 34(1):108-11. PubMed ID: 25741804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro 24-hour time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus.
    Singh SR; Bacon AE; Young DC; Couch KA
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4495-7. PubMed ID: 19635959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.